Consumption of fossil fuels has increased indoor and outdoor concentrations of polycyclic aromatic hydrocarbons (PAHs) and nitrogen dioxide (NO2). To study the combined effect of PAH administration and NO 2 exposure on mutagenicity of urine from animals we injected 400 mg/kg body wt i.p. one of five kinds of PAH (pyrene, fluoranthene, fluorene, anthracene and chrysene) into ICR mice, Wistar rats, Syrian golden hamsters or Hartley guinea pigs after exposure to 20 p.p.m. NO 2 gas for 24 h and then exposed the animals to NO 2 gas for an additional 24 h. During the latter 24 h we collected the urine and assayed its mutagenicity with the Ames Salmonella strains after treatment with p*-glucuronidase and arylsulfatase and extraction with dichloromethane. The urine from mice treated with both PAH and NO 2 showed high mutagenicity for Salmonella typhimurium strains TA98 and TA100, whereas the urine from mice treated with PAH and air showed almost no mutagenic activity. The mutagenicity was decreased in nitroreductase-and acetyltransferasedeficient strains TA98NR and TA98/1,8-DNP 6 respectively. Treatment with a mixture of 20% of each of the five kinds of PAH and NO 2 augmented the urinary mutagenicity of mice 1.5-fold. The urine from hamsters treated with pyrene or fluoranthene and NO 2 was also highly mutagenic, but that from rats or guinea pigs was not very mutagenic. The mutagenicity was also decreased in strains TA98NR and TA98/1,8-DNP 6 . These results suggest that the urine contains nitro compounds and that the nitration of PAHs occurs in the body of animals under exposure to NO 2 gas. Actually, the nitrated metabolites of pyrene, l-nitro-6/8-hydroxypyrene and l-nitro-3-hydroxypyrene, were detected in the urine from mice treated with pyrene under exposure to NO 2 gas. To elucidate the mechanism of in vivo nitration, NO 2 (20 p.p.m.) was bubbled through 50 mM Tris-HCl buffer (pH 7.4) or dichloromethane solution containing pyrene or 1-hydroxypyrene (10 |ig/ml). Pyrene was not nitrated by NO 2 in either aqueous or organic solutions. However, 1-hydroxypyrene was changed to nitrohydroxypyrenes by NO 2 in the Tris-HCl buffer, but not in the •Abbreviations: PAH, polycyclic aromatic hydrocarbon; NP, nitropyrene; 6/8-nitropyrenol, l-nitro-6/8-hydroxypyrene; 3-nitropyrenol, 1-nitro-3-hydroxypyrene; 1-pyrenol, 1-hydroxypyrene; vitamin E, DL-ot-tocopherol; vitamin C, L-ascorbic acid; AF-2, 2-(2-furyl)-3-(5-nitro-2-furyl)-acrylamide; 2-AA, 2-aminoanthracene; 1,6-diNP, 1,6-dinitropyrene; DMSO, dimethyl sulfoxide.
Introduction
Nitrogen dioxide (NO 2 ) is present in the environment as a result of various combustion processes, such as power generation from fossil fuels, gas cooking and automobile exhaust (1-4). Consumption of fossil fuels also increases the concentration of polycyclic aromatic hydrocarbons (PAHs*) in the ambient air (5) (6) (7) (8) . Cigarette smoke contains very high levels of NO 2 (9) . Therefore, we are exposed to both NO 2 and PAHs every day. Some of the biological effects of environmental exposure to NO2 are well established. NO 2 causes morphological and physiological changes in the pulmonary epithelium resulting in lung tissue damage (10, 11) . Although the general toxic effects of NO 2 have been thoroughly studied, there is little information concerning the genotoxicity of NO 2 (12) . In addition, there are only a few reports concerning the combined effects of PAHs and NO 2 . Pitts et al. (13) demonstrated that atmospheric reaction of PAHs such as benzo [a] pyrene and perylene with 1 p.p.m. of NO 2 for 24 h leads to the formation of mutagenic nitro derivatives. Tokiwa et al. (14) also reported the formation of nitro derivatives from pyrene, penanthrene, fluorene, chrysene, carbazole and fluoranthene by exposure to 10 p.p.m. of NO2 for 24 h. In vitro exposure of the PAHs to NO 2 produces nitroarenes, which are more mutagenic than the parent compounds, as detected with the Ames Salmonella mutagenicity test. Concerning an in vivo combined effect of PAH and NO 2 , we showed that when mice are administered pyrene and exposed to NO 2 , mutagenic nitropyrene (NP) derivatives such as l-nitro-6/8-hydroxypyrene (6/8-nitropyrenol, a mixture of l-nitro-6-hydroxypyrene and l-nitro-8-hydroxypyrene) and l-nitro-3-hydroxypyrene (3-nitropyrenol) are formed and excreted into the urine (15,16). We also showed that the urinary mutagenicity is dependent on both the dose of NO 2 and the pyrene concentration (17,18). These results suggest that nitration of pyrene occurs in the body of mice under exposure to NO 2 . Therefore, non-or weakly mutagenic PAHs may be easily transformed to more highly mutagenic nitro derivatives by in vivo exposure to NO 2 , as well as in vitro. In addition, some of the nitroarenes have been shown to be mutagenic in bacteria and cultured mammalian cells and tumorigenic in experimental animals (19-21).
In this study we investigated the combined effect of administration of various kinds of PAHs and NO 2 exposure on the mutagenicity of urine from mice and also investigated species differences in mulagen formation by a combination of PAH administration and NO : exposure. Furthermore, to elucidate the mechanism of in vivo nitration of pyrene upon exposure to NO : . pyrene and l-hydroxypyrene (l-pyrenol) were exposed to NO-, in vitro in aqueous or organic solution
Materials and methods

Chcnih als
Pyrene. chrysene. 1-NP and anthracene were ohl.uncd troni Aldrn.li Chcmic.il Co (Milwaukee. Wl I (ilul.ilhione I reduced torml. hemoglobin. (3-glucuronidase (type VII). arylsultatase (type V) glucose 6-phosphate undtne-Vdiphosphoglucuronic acid and undme 5'-diphosphoglucuronyl transterase were purchased Irom Sigma Chemical Co (Si Louis. MOl NADP was ohtained Irom Onenlal Yea.sl Co Ltd (Tokyo. Japanl Fluorene. IHioranlhenc. I -.iseorbic acid (\itamin C). m -rx-locopherol I vitamin H). oleic aud mannilol ammonium sullamale unc acid, glycerol 2-(2-luryl )-3-< 5-nitro-2-furyl l-acrylamide IAF-2). 2-aminoanlhraccne (2-AAl. tn-/i-capr\lin. in-/i-hulyl phosphate, phenoharbital. 5.6-benzollavone and other chemicals, reagent grade or higher, were obtained liom Wako Pure Chemical Industries Ltd (Osaka. Japanl I-NP metabolite standards were kindly supplied bv I)r FA Belaud (National Center tor Toxicologieal Reseaieh. AR) aiul prepared as desLnbed previously (22-24) l-Pyrenol and 1.6-duutropyrene ( 1.6-diNP) were synthesized according to the procedures ol Manabe el al (24) and Hashimoto ami Shudo (2?) respectively I-NP and 1.6-diNP were punhed bv HPLC as described previously (26 28) The purity ol the chemicals has been described previously (24,29) and that ol l-pyrenol was 44 l'/< |3 S'i pyrene) The glucuromde con|Ugate ol l-pyrenol w.is synthesized enzymaticallv with undine-5'-diphosphoglucuronic acid and undme V-diphosphoglucuronyl translerase or rat hvei microsomes (23) Rat liver microsomes were prepared as described previously (30) NO> uas diluted with air was obtained Irom Sumitomo Seik.i Chemicals Co Ltd (Osaka. Japan)
Mittagenu il\ as sa\ s
Mulagentcily was assayed with two plates per sample bv the preincubation method (37°C lor 20 mm) .is described by Maron and Ames (31) with Salmonella Ivpliiimoiiim strains TA I(K). TA9S. TA9SNR and TA9S/1.S-DNP,, Liver S9 from Sprague Daw ley rats treated with phenoharbit.il and 5.6-ben/ofla\one (32) was useil at a concentration ot 50 |.tl/plate lor exogenous iiK'tabohc activation The number ol revertants was calculated trom the linear portion ol the dose response curves AF-2. 2-AA. I-NP and 1.6-diNP were used as standard compounds The average numbers of spontaneous reveriants were 24 (TAW.
S9|. 34 ITA48. t.S9) 113 (TAKM). S9). US (TAI00. fS4). IS (TA9SNR. S9) and 14 (TA98/I .S-DNP,,. S9| AF-2 (0 02 pg) induced 235 revertants/plale Irom strain TA98 and 775 reverlanls/plate Irom strain TAKK) without S9 mi\ 2-AA |2 ug) induced 1172 ITA9S ^S9) and 1261 ITAKH). i S9) revenanls/plate I-NP (0025 p.g) induced 464 (TA9S S9) and 32 (TA98NR. S9i revertants/plale 1.6-diNP (2 ngl induced 689 (TA98. S9> and 102 (TA9S/I .S-DNP 6 . S4) revertants/plate The number ol spontaneous revertanls was subtracted in all the data on mutagenicity
Annuals ami tieatment
Five-week-old male IC'R mice (weighing 24 26 g). Wistar rats i9l)-ll() g) Syrian golden hamsters (50-40 g) and Hartley guinea pigs O00-350 g) were purchased Irom SLC Japan iHamamatsu. Japan) We in|ected 400 mg/kg body wt ip ot PAH (pyrene. tluoranthene. tiuorene anthracene or chrysene) dissolved in tri-/i-capryhn or a mixture ol SO mg/kg ol each of the five kinds 01 PAH into the animals One or a lew animals were housed in a glass metabolic cage with a si\ litter capacity (Metabohca. Sugiyama-gen Tokyo. Japan) and exposed to air or 20 ppm NO; at a Mow rate of 350 ml/mm Alter 24 h exposure to NO* they were given either a single PAH or a PAH mixture and then exposed to NO; lor an additional 24 h During the latter 24 h urine was collected in ice-cooled containers and was passed through a membrane filter (pore si/e 0 45 uni) We also collected the bladder urine of mice treated with pyrene and NOT with a needle under anesthesia 24 h after PAH administration NO; concentration was monitored with Ga.stec model HOI (Gaslec, Yokohama, Japan) The urine sample (3 ml) was mixed with 0 3 ml of 2 M acetate butler (pH 6 0) and treated with [3-glucuronidase ( KKX) U/ml) and arylsullatase (5 I'/ml) at 37°C lor 16 h The en/.yme-treated urine was extracted with an equal volume ot dichloromethane three limes ami evaporated by a concentrator iTomy CC-180. Tomy Seiko Co Ltd. Tokyo. Japan) The residues were dissolved in 600 ul ol dimethyl sulfoxide (DMSO) and the mutagenicitv was assayed with the Ames Salmonella strains listed above To study the eflect ol vitamins on urinary mutagenicity. we administered 2 gAg body wt vitamin C dissolved in saline or vitamin E dissolved in com oil by gavage in the stomach |ust belore I p in|ection ol pyrene (49 5 ^iM). l-pyrenol (45 9 |.iM) or the glucuronide conjugate of l-pyrenol (464 p.M) in 50 niM Tns HCI bullei ipH 7 4) at 37°C Samples (0 7 ml) were removed at appropriate times and extracted with an equal volume of dichloromethane three tunes When the glucuronide conjugate was used, the samples were treated w ith |5-glucuronidase as described previously (33) and extracted with An equal volume of dichloromethane The extracts vvea' concentrated in vat no and the residues were dissolved in 70 pi DMSO and analyzed by HPLC NO; was also bubbled through a solution of pyrene or l-pyrenol in the dichloromethane al 25°C as described above Samples were removed, concentrated, dissolved in DMSO and analyzed by HPLC
N()-> bubbling through mouse blood t ontaimn^ I-pxienol
Blood was collected with a hepanniz.ed needle and lubes Irom the hearts o( ICR mice mule. 5 weeks old) previously exposed to 20 p p m NO; gas for 24 h l-Pyrenol ( 10 (ig/ml. 45 9 uM) was mixed with the hlcxxl and 20 p p in NO; gas was bubbled at 50 ml/mm at 37°C for It) or 60 mm In the case ol the 60 mm exposure a few drops of ln-»-bulyl phosphate were added to prevent foaming After extraction with dichloromethane as desLnbcd above, the extracts were concentrated, dissolved in DMSO and analyzed by HPLC
Efjei 1 of some toniponmls on in vino nitration of l-pvrenol
Vitamin E and oleic acid were dissolved in dichloromethane and diluted with DMSO Vitamin C. glutathione. mannilol. ammonium sullamale. uric acid, glycerol and hemoglobin were dissolved in distilled water BUMXI was collected from ICR mice previously exposed to NO; gas as desenbed above Serum was prepared Irom non-hepannized blood of NO;-treated mice NO; gas (20 p.p m ) was bubbled through a l-pyrenol (10 p.g/ml) solution containing these compounds at 50 ml/mm at 37°C lor 1 UMU Alter extraction ot the products trom the reaction mixture with dichloromethane. 6/S-nilropyrenol was quantified by HPLC
Itlenlifiialion oj nitrated lompounds prodiu ed fiom l-p\renol in vilio
NOi gas was bubbled through l-pyrenol (II) ug/ml) in 50 mM Tns HCI buffer (pH 7.4) as described above The nitrated products were separated by HPLC. collected and concentrated //( vaeuo Electron impact mass spectra were recorded with a JMS-D3IK) (Jeol. Tokyo. Japan) mass spectrometer Ionizing voltage and current were 70 eV and 2(X) (.lA respectively A Hewlett Packard HPKHOA high speed spectrophotometric detector was used to obtain UV spectra ol the products 
The values shown are the mean±SD. "Difference in the mutagenicity between the subtotal and mixture is significant (P < 0.01). Difference is significant (P < 0.05).
HPLC HPLC was conducted with a Shimadzu LC-6A instrument equipped with a Shimadzu SPD-2A variable wavelength UV detector. The products were separated with a reversed phase column, Chemocosorb 7-ODS-H (4.6 X 250 mm; Chemco Scientific Co. Ltd, Osaka, Japan) and monitored at 240 nm. The column temperature was maintained at 50°C. Methanol (70%) was used for analysis of the nitrated products and 65% methanol was used to collect the products for identification. The flow rate of the solvent was 1.0 ml/min.
Statistics
Mutagenicity of the unne samples was compared by one-way analysis of variance.
Results
Mutagenicity of urine from mice treated with PAHs and NO2
The urine from mice treated with PAHs and exposed to air showed almost no mutagenic activity. However, when mice were treated with a PAH, especially pyrene or fluoranthene, and exposed to NO2 their urine showed high mutagenicity for S.typhimurium strain TA98 and TA100 in the absence and presence of S9 mix (Table I ). The mutagenicity of urine was highest for strain TA98 without S9 mix, except in fluoranthenetreated mice, and it was decreased in nitroreductase-and acetyltransferase-deficient strains TA98NR and TA98/1.8-DNP 6 (Table I ). The mutagenicity of urine from mice treated with anthracene, fluorene or chrysene and exposed to NO 2 was lower than that of urine from pyrene-or fluoranthenetreated mice in strain TA98 without S9 mix (Table I) . Mutagenicity was also detected in bladder urine from mice treated with pyrene and NO 2 (Figure 1) . Treatment of mice with a mixture of 20% of the five kinds of PAH and NO 2 augmented the mutagenicity of mouse urine ~ 1.5-fold as compared with the calculated mutagenicity corresponding to the subtotal of 20% of the mutagenicity of urine from mice treated separately with each PAH (400 mg/kg) and NO 2 (Table H) .
Species differences in urinary mutagenicity
To study species differences, we measured the mutagenicity of urine collected from various kinds of animals treated with pyrene or fluoranthene and NO 2 . Urine from hamsters was highly mutagenic, the same as that from mice, but urine from rats and guinea pigs was not very highly mutagenic (Table HI) .
Effect of vitamin C and vitamin E on urinary mutagenicity of mice treated with pyrene and NO2
The urinary mutagenicity of mice treated with pyrene and NO 2 was inhibited by administration of vitamin C and vitamin E. Vitamin C was more effective than vitamin E. Inhibition was 64.6-71.7% in the vitamin C-treated group and 26.4-51.3% in the vitamin E-treated group (Table TV) .
In vitro nitration of pyrene, 1-pyrenol and glucuronide conjugate of 1-pyrenol in aqueous and organic solvents by bubbling with NO 2 In 50 mM Tris-HC1 buffer (pH 7.4) pyrene was not consumed and nitrated products were not produced even after 3 h exposure to NO 2 (Figure 2a and b) . On the other hand, 1-pyrenol was consumed within 4 min after NO 2 bubbling in 50 mM Tris -HC1 buffer (Figure 2c and d) . Four products (A, B, C and D) were produced; the retention times of products A and D corresponded to those of 6/8-nitropyrenol and 3-nitropyrenol respectively. In the organic solvent pyrene was not decreased and nitrated products were not observed after 5 h exposure to NO 2 . 1-Pyrenol decreased, but more slowly than in aqueous solution and small amounts of products A, B and D were detected. In this case the main product was eluted at a retention time of 40 min, which was different from the nitropyrenols (Figure 3) . The glucuronide conjugate of l-pyrenol was incubated for 3 h in Tris-HCI buffer with or without NO : bubbling and fjglucuronidase-released aglycons were analyzed by HPLC. Nitrated products were not detected under either condition (data not shown). When 49.5 (iM l-pyrenol in blood collected from NO^-exposed mice was treated by NO : bubbling for 10 or 60 min l-pyrenol was not decreased and the nitrated products 6/8-nitropyrenol and 3-nitropyrenol were not detected (data not shown). These nitrated products (A -D) produced from l-pyrenol by NO : bubbling in Tris-HCI buffer (pH 7.4) were the same as the in vivo products in urine from mice treated with pyrene and NO 2 ( Figure 4) .
Identification of nitrated products produced from I-pvrenol in aqueous solution
Nitrated products produced from l-pyrenol by NO : blowing in Tns-HCI buffer were purified by HPLC. The retention times and UV visible spectra of products A and D were identical to those of authentic 6/8-nitropyrenol and 3-nitropyrenol respectively. In mass spectrometry analysis molecular ion peaks of products A -D appeared at 263 ( Figure 5 ) 
1-Pyrenol
In vivo Therefore, we identified product A as 6/8-nitropyrenol and product D as 3-nitropyrenol. Products B and C may be other nitropyrenols. 
Effect of some compounds on nitration of J-pyrenol in Tris-HCI buffer
We examined the effect of vitamins, antioxidants and blood components to try to determine the mechanism of nitration. Vitamin C was the most effective, completely inhibiting the production of 6/8-nitropyrenols at 1 mM. Vitamin E at 1 mM, 1 mM glutathione, 1 mM oleic acid and 5 mg/ml hemoglobin also inhibited nitration by 70-80% (Table V) . Mouse blood and serum showed dose-dependent inhibition of 6/8-nitropyrenol production. Mannitol, ammonium sulfamate and uric acid were not effective. Glycerol slightly inhibited nitration, at 0.1% (Table V) .
Discussion
To study the combined effect of PAH administration and NO 2 exposure, we determined the mutagenicity of urine from animals treated with PAHs and NO2 or air. Urine samples from PAH/air-treated animals showed almost no mutagenicity, but those from PAH/NO : -treated animals showed high mutagenic activity. The mutagenicity was decreased in S.typhimurium strains TA98NR and TA98/l,8-DNP 6 . These two strains were isolated as nitrofuran-or l.8-diNP-resistant strains and lack the enzymes nitroreductase or acetyltransferase respectively, which are required to activate nitroarenes such as I-NPtype mutagens and diNP-type mutagens respectively (20,34). These results suggest that the urine from animals treated with PAHs and NO 2 contained mutagenic nitro compounds. In addition, we reported previously that urine from mice treated with pyrene and NO : was highly mutagenic for strain TA98 and was found to contain glucuronide conjugates of 3-nitropyrenol and 6/8-nitropyrenol by HPLC analysis (15-18). Therefore, the mutagenic compounds in urine may be nitrated derivatives of the PAH administered. The mutagenicity of urine from mice treated with pyrene or fluoranthene and NO : was higher than that of mice treated with anthracene, chrysene or fluorene and N(X This may be due to the higher mutagenicity of nitropyrene or nitrofluoranthene derivatives than that of nitrochrysene, nitroanthracene or nitrofluorene derivatives (19.20) or to a difference in nitration specificity among the compounds.
To study species differences, we determined the mutagenicity of urine from various kinds of animals treated with pyrene or fluoranthene and NO : . Urine from hamsters and mice was highly mutagenic. as shown in Tables I and III. but that from rats and guinea pigs was not very mutagenic. These results suggest that the nitration of PAHs occurs in the body of animals, probably including the human body, under exposure to NCK The levels of mutagenicity seem to be dependent on the tidal volume/kg body wt/min: mouse. 515 ml; hamster, 445 ml; rat. 182 ml; guinea pig. 203 ml; human. 125 ml (calculated from the data in 35.36). Although the tidal volume/ kg/min of humans was 125 ml. ~4-fold lower than that of mice and hamsters, nitration may occur in the human body. The levels of the mutagenicity were also inversely proportional to the LD 5( ) of NO 2 in various kinds of animals exposed for 16 h: mouse 38 p.p.m.; hamster. 28 p.p.m.; rat. 49 p.p.m.; guinea pig, 62 p.p.m. (37) . In addition, the combination of administration of small amounts of PAH mixture and NO : exposure showed augmentative mutagenicity (Table II) . Twenty p.p.m. exposure of NO : is not beyond human exposure, because cigarette smoke contains 80-120 p.p.m. NO; (9) . We also detected urinary 1-pyrenol in elementary school children and showed that the urinary 1-pyrenol levels in the children who live in areas of Tokyo along arterial roads were higher than those of children in the less polluted suburban area (38) . These results are important for humans, especially smokers, because we are exposed to NO : and small amounts of various PAHs every day.
The fate of NO : in the living body has been investigated by using a stable isotope of nitrogen (39). The results demonstrated that 50-60% of the inspired NO : is absorbed by primates during quiet respiration. Once absorbed. NOi or chemical intermediates remain inside the lungs for longer periods than Xe, a control compound, and are disseminated to extrapulmonary sites via the blood stream. NO; possibly reacts with water in the nasopharynx and lung to form nitnc and nitrous acids (39). The reaction of these acids with pulmonary and extrapulmonary tissue probably accounts for the biological toxicity of NO 2 .
When Iqbal et al. (40) treated mice with both morphohne and NO 2 , froze the mice and then extracted the products with a solvent, they detected /V-nitrosomorpholine in the extracts. The amount of /V-nitrosomorpholine produced was dependent on both NO; exposure time and concentration of NO : . In similar experiments NO : gave rise to the in vivo nitrosation of dimethylamine (41). Mirvish et al. (42) have disputed Iqbal's interpretation and suggest that the observed nitrosation is a result of artifactual formation during the sample preparation, which may be due to formation of long-lived nitrosating intermediates on the skin during exposure to NO : . In addition, Mirvish et al. (43) have shown that when morpholine was painted on the skin of mice which were then exposed to NO 2 , N-nitrosomorpholine was formed on the skin. However, mutagenic nitro derivatives formed from parent PAHs in vivo in our experiments were not artifacts, because the bladder urine of mice treated with both pyrene and NO 2 also showed mutagenic activity toward S.typhimurium (Figure 1) .
We have demonstrated that highly mutagenic nitropyrenols were produced in vivo in pyrene-treated mice during exposure to NO 2 . Pyrene or its metabolites must be nitrated in vivo. To elucidate the mechanism of in vivo nitration by NO 2 , we exposed pyrene or its in vivo metabolites, 1-pyrenol and the glucuronide conjugate of 1-pyrenol, to NO 2 by bubbling the gas through polar and non-polar solvents. Pyrene itself was not nitrated in either solvent (50 mM Tris-HCl buffer, pH 7.4, and dichloromethane). 1-Pyrenol was quickly decreased and changed to nitropyrenols by blowing NO 2 into 50 mM Tris-HCl buffer. The HPLC profile of these in vitro nitrated products was similar to that of the in vivo products (Figure 4 ). 6/8-Nitropyrenol and 3-nitropyrenol were identified as both in vitro and in vivo nitrated products. However, scarcely any nitration of 1-pyrenol occurred in dichloromethane. Glucuronide conjugates of 1-pyrenol were not nitrated. These results indicate that pyrene is first metabolized to 1-pyrenol in vivo and then 1-pyrenol is nitrated during exposure to NO 2 .
There are three mechanisms for the nitration of PAH (44): (i) ionic electrophilic aromatic substitution in a polar environment (45) ; (ii) a gas phase reaction initiated by hydroxyl radical (46) ; (iii) a radical mechanism in the gas phase and a non-polar solvent (47) . Since pyrene must exist as a soluble form in the animal body, the gas phase reaction cannot occur. Nitropyrenols were produced from 1-pyrenol only by bubbling NO 2 through Tris-HC1 buffer. Therefore, in vivo nitration by NO 2 must occur via ionic electrophilic substitution of hydrogen on the pyrene ring of 1-pyrenol by a nitronium ion produced from NO 2 in a polar environment.
Products A and D ( Figure 4 ) were identified as 678-nitropyrenol and 3-nitropyrenol respectively. Products B and C may also be nitropyrenols, because their molecular ion peaks appeared at 263, the same position as standard nitropyrenols. Howard et al. (23) analyzed synthetic standards of 1-NP derivatives by reversed phase HPLC and demonstrated that nitropyrenols 6/8-nitropyrenol, 5-nitropyrenol, 4/9-nitropyrenol and 3-nitropyrenol were eluted in that order. Kanoh et al. (16) identified product B as 9-nitropyrenol. These data suggest that products B and C were probably produced by substitution of hydrogen at positions 4, 5 or 9 by nitronium ions. The reactive sites of 1-pyrenol were positions 3, 6 and 8 and K regions of the pyrene ring. Therefore, it is reasonable to postulate that the metabolites were 6/8-nitropyrenol, 3-nitropyrenol and K region nitropyrenols, probably 5-and 9-nitropyrenols.
In a polar environment NO 2 gas is dissolved in water and changed to HNO3 and HN0 2 . Nitronium ions are formed from HNO3 and nitrosonium ions are formed from HNO2 and HNO3. Vitamin C was the strongest inhibitor of nitration by NO 2 both in vivo and in vitro. This vitamin is an outstanding antioxidant (48) and reduces nitrate to nitrite efficiently. On the other hand, ammonium sulfamate, which degrades HNO 2 to N 2 gas, did not inhibit nitration (Table V) . These results indicate that electrophilic substitution of 1-pyrenol occurs only with nitronium ions, and that the nitrosonium ion is not involved. Although glycerol reacted with the nitronium ion, the inhibitory effect was small, probably owing to its low concentration.
Vitamin E, glutathione and hemoglobin also inhibited nitration by NO 2 , because these compounds are radical scavengers and therefore they eliminate the NO 2 radical and inhibit the formation of the nitronium ion. Since unsaturated fatty acids react with NO 2 (49) , oleic acid competitively inhibited the nitration of 1-pyrenol. These results are consistent with the lack of production of nitropyrenols in mouse blood, because blood contains many kinds of antioxidants, radical scavengers and free fatty acids.
It is still unknown where in vivo nitration of 1-pyrenol by NO 2 exposure occurred. However, nitration cannot occur in blood for the reasons stated above. It is possible that the administered pyrene was metabolized to 1-pyrenol in the liver or lung and that 1-pyrenol was distributed to the lung and was nitrated with nitronium ions in the lung, where NO 2 was dissolved into the aqueous phase, converted to HNO 3 and changed to nitronium ion. Actually, we detected 1-pyrenol in a homogenate of lung from rats treated with tritiated pyrene (data not shown). Nitration in other organs such as the liver may be difficult, because NO 2 , HNO 3 and the nitronium ion will be easily reduced by vitamin C or other blood components before reaching these organs.
In view of these results, we conclude that 1-pyrenol is nitrated by an ionic reaction in the animal body, probably in the lung, after hydroxylation of pyrene in the liver. Therefore, when PAHs are inhaled together with NO 2 , they would be nitrated in vivo and changed to mutagenic/tumorigenic nitro compounds.
